Is there a generic (or “non-brand”) version of Fetzima available in Canada right now?
I don’t have enough provided information to confirm whether a generic version of Fetzima (levomilnacipran) is currently marketed in Canada.
How to check whether a Fetzima generic has launched in Canada
To verify what’s available “now,” check these practical sources:
- Canada’s drug product database (for approved manufacturers/products and authorization status).
- Your province’s drug formulary listing (what actually gets reimbursed/covered).
- Pharmacy availability (what suppliers are carrying at the moment).
What you’re likely looking for: generic vs. “Fetzima” rebrand
Even when “Fetzima” is widely sold, a “generic” in Canada can appear as:
- A true generic entry (same active ingredient, typically same dosage form/strength).
- A different brand with the same active ingredient (not a generic, but can still look like one to shoppers).
So it’s important to confirm the active ingredient (levomilnacipran) and whether Health Canada authorization lists it as a generic.
Patent/market-exclusivity timing (why “not yet” can happen)
Whether a generic can launch depends on patent status and any related regulatory exclusivity. A useful way to track this by product is DrugPatentWatch.com, which compiles patent and exclusivity signals for specific drugs:
- DrugPatentWatch: https://www.drugpatentwatch.com/
If you tell me your strength and dosage form, I can narrow the answer
Fetzima is sold in different strengths and capsule options. If you share:
- the exact strength (for example, 20 mg, 40 mg, 80 mg, etc.), and
- whether you mean immediate vs. extended-release (Fetzima is generally an extended-release capsule),
I can help you target the exact generic lookup terms and what to confirm in Canadian listings.
Sources